PCVX — VAXCYTE INC

Ownership history in Bridgefront Capital, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Bridgefront Capital, LLC reported a position in VAXCYTE INC (PCVX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.34% (2024 Q1)
Avg. % of fund
0.19%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 24,325 +13,617 +127.2% 0.26% $876K $36.02
2025 Q2 ADDED 10,708 +6,464 +152.3% 0.09% $348K $32.51
2024 Q4 ADDED 4,244 +172 +4.2% 0.12% $347K $81.86
2024 Q3 REDUCED 4,072 -2,522 -38.2% 0.18% $465K $114.27
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PCVX price (monthly, adj. close)

Other funds also holding PCVX

As of 2025 Q4 — sorted by position size

Pivotal bioVenture Partners Investment Advisor LLC 3Y 24.48% Kynam Capital Management, LP 3Y 8.61% Saturn V Capital Management LP 3Y 6.77% Caligan Partners LP 3Y 6.48% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 5.07% Paradigm Biocapital Advisors LP 3Y 4.79% Elmind Capital, LP 3.97% Deep Track Capital, LP 3Y 3.29% Novo Holdings A/S 3Y 7Y 3.28% Eversept Partners, LP 3Y 7Y 2.78%
← Back to Bridgefront Capital, LLC Holdings